Skip to Content

Institute for Applied Cancer Science

Carlo Toniatti, M.D., Ph.D. - Head of Research

Carlo Toniatti joins the Institute for Applied Cancer Science as Head of Research after more than twenty years of experience in basic research, drug discovery and clinical development in both a biotech and a pharmaceutical company environment. He has substantial expertise in oncology and also in gene therapy and RNA- interference, recombinant growth factors and transcriptional regulation.  

Throughout his career, Toniatti successfully led multiple programs and cross-functional teams and has gained substantial experience in leading different oncology drug discovery programs—including PARP, Wee1, Chk1 and HDM2 inhibitors programs—from target identification/validation to clinical phase 1-2 trials and in executing on translational research for the therapy of biomarker-defined tumor subtypes. He is also experienced in the management of external collaborations and alliances and in portfolio management.

Toniatti received an M.D. degree at the University of Naples, Italy and a Ph.D. in Molecular and Cellular Biology and Pathology at the University of Naples, Italy.

© 2015 The University of Texas MD Anderson Cancer Center